{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:54:01Z","timestamp":1775696041307,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["2021002358"],"award-info":[{"award-number":["2021002358"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["14002\/2021\\u20132"],"award-info":[{"award-number":["14002\/2021\\u20132"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017489","name":"Dutch Colorectal Cancer Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejca.2026.116668","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:15:29Z","timestamp":1772900129000},"page":"116668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-6216","authenticated-orcid":false,"given":"Dania","family":"Al-Toma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby","family":"Kemna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-6323","authenticated-orcid":false,"given":"Mahsoem","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-4509","authenticated-orcid":false,"given":"Koen","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-5404","authenticated-orcid":false,"given":"Michiel J.","family":"Zeeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertine L.","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Kurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-4331","authenticated-orcid":false,"given":"Manon N.G.J.A.","family":"Braat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.W.","family":"Lagendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-3790","authenticated-orcid":false,"given":"Anne M.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inez M.","family":"Verpalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-4634","authenticated-orcid":false,"given":"Rutger-Jan","family":"Swijnenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis J.A.","family":"Punt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-3823","authenticated-orcid":false,"given":"Guus M.","family":"Bol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9980","key":"10.1016\/j.ejca.2026.116668_bib1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(14)62004-3","article-title":"Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group","volume":"385","author":"Simkens","year":"2015","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ejca.2026.116668_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1470-2045(15)00042-X","article-title":"Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial","volume":"16","author":"Hegewisch-Becker","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116668_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116668_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.4489","article-title":"The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials","volume":"6","author":"Sonbol","year":"2020","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116668_bib5","article-title":"Revolutionizing radiology with artificial intelligence","volume":"16","author":"Bhandari","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.ejca.2026.116668_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s11548-024-03181-4","article-title":"Improving assessment of lesions in longitudinal CT scans: a bi-institutional reader study on an AI-assisted registration and volumetric segmentation workflow","volume":"19","author":"Hering","year":"2024","journal-title":"Int J Comput Assist Radio Surg"},{"issue":"1","key":"10.1016\/j.ejca.2026.116668_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13244-024-01820-7","article-title":"Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA)","volume":"15","author":"Bereska","year":"2024","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejca.2026.116668_bib8","first-page":"1","article-title":"From development to implementation: a systematic review on the current maturity status of artificial intelligence models for patients with colorectal cancer liver metastases","author":"Kemna","year":"2025","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2026.116668_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114160","article-title":"Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis","volume":"207","author":"Cohen","year":"2024","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116668_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116668_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejca.2026.116668_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/SLA.0000000000002064","article-title":"The Tumor Burden Score: A New \"Metro-ticket\" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors","volume":"267","author":"Sasaki","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2026.116668_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115738","article-title":"Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial","volume":"228","author":"Michiel Zeeuw","year":"2025","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116668_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000103","article-title":"The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment","volume":"2","author":"Wesdorp","year":"2021","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.ejca.2026.116668_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114185","article-title":"Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation","volume":"207","author":"Michiel Zeeuw","year":"2024","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2026.116668_bib16","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1245\/s10434-025-17295-9","article-title":"Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases","volume":"32","author":"Lindenlaub","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116668_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1365-2125.2012.04179.x","article-title":"The use of tumour volumetrics to assess response to therapy in anticancer clinical trials","volume":"73","author":"Goldmacher","year":"2012","journal-title":"Br J Clin Pharm"},{"issue":"8","key":"10.1016\/j.ejca.2026.116668_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.21484","article-title":"Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma","volume":"14","author":"Toso","year":"2008","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.ejca.2026.116668_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/2159-8290.CD-14-0462","article-title":"Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution","volume":"4","author":"Misale","year":"2014","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.ejca.2026.116668_bib20","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/annonc\/mdx322","article-title":"Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study","volume":"28","author":"Goey","year":"2017","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116668_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejca.2026.116668_bib22","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-207168","article-title":"British Thoracic Society guidelines for the investigation and management of pulmonary nodules","volume":"70","author":"Callister","year":"2015","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.ejca.2026.116668_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116668_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134732","article-title":"Impact of pre-treatment lactate dehydrogenase levels on prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer","volume":"10","author":"Passardi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.116668_bib25","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v070.i08","article-title":"flexsurv: A Platform for Parametric Survival Modeling in R","volume":"70","author":"Jackson","year":"2016","journal-title":"J Stat Softw"},{"issue":"5","key":"10.1016\/j.ejca.2026.116668_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ijc.34760","article-title":"Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212)","volume":"154","author":"Sommerh\u00e4user","year":"2024","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116668_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-025-01984-w","article-title":"Evaluation of a deep-learning segmentation model for patients with colorectal cancer liver metastases (COALA) in the radiological workflow","volume":"16","author":"Zeeuw","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejca.2026.116668_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejca.2018.05.010","article-title":"Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group","volume":"100","author":"Goey","year":"2018","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492600448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492600448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:15:36Z","timestamp":1775693736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492600448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"alternative-id":["S095980492600448X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116668","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116668"}}